Company Description
OptimizeRx Corporation, a digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients.
The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail.
It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms.
The company was founded in 2006 and is based in Waltham, Massachusetts.
| Country | United States |
| Founded | 2006 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 129 |
| CEO | Stephen Silvestro |
Contact Details
Address: 260 Charles Street, Suite 302 Waltham, Massachusetts 02453 United States | |
| Phone | 248-651-6568 |
| Website | optimizerx.com |
Stock Details
| Ticker Symbol | OPRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001448431 |
| CUSIP Number | 68401U204 |
| ISIN Number | US68401U2042 |
| Employer ID | 26-1265381 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Stephen L. Silvestro | President and Chief Executive Officer |
| Edward Stelmakh C.M.A., M.B.A. | Chief Financial Officer and Chief Operating Officer |
| Andrew Jacob D'Silva | Senior Vice President of Corporate Finance |
| Marion K Odence-Ford | Chief Legal Officer and Chief Human Resources Officer |
| Maira Alejandra | Media Relations Manager |
| Dr. Doug Besch | Chief Product Officer and Chief Technology Officer |
| Theresa Greco | Chief Commercial Officer |
| Heather Favazza | Controller |
| Sheryl Kearney | Human Resources Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 21, 2025 | SCHEDULE 13D/A | Filing |
| Apr 18, 2025 | 8-K | Current Report |
| Apr 7, 2025 | EFFECT | Notice of Effectiveness |
| Mar 28, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Mar 20, 2025 | 10-K | Annual Report |
| Mar 12, 2025 | 8-K | Current Report |
| Mar 11, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 11, 2025 | DFAN14A | Filing |
| Mar 10, 2025 | SCHEDULE 13D/A | Filing |
| Mar 10, 2025 | 8-K | Current Report |